Patent · US Active

Method of treating prostate cancer

US11207311B2 · kind B2 · utility

5Cited by

2References

23Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Marco Gottardis · Princeton, US
Rebecca Hawkins · Harleysville, US
Linda Snyder · Pottstown, US
Douglas H. Yamada · Philadelphia, US

Key dates

Filing date	Sep 14, 2018
Grant date	Dec 28, 2021
Priority date	—
Expiry date	Sep 14, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are methods of treating prostate cancer by administering niraparib to a human in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.